CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in consumer awareness & incidences of diseases
4.1.2. The shift in consumer preferences towards healthy food
4.1.3. Participation of international bodies in R&D of probiotic products
4.1.4. The upsurge in the consumption of functional foods
4.2. Market Restraints & Challenges
4.2.1. Complexities in integrating probiotics in functional foods
4.2.2. High operating costs
4.2.3. International quality standards and regulations for probiotics products
4.3. Market Opportunities
4.3.1. Improved standards of living in developing economies
4.3.2. The ban on the use of antibiotics in animal feed
CHAPTER 5 GLOBAL PROBIOTICS MARKET – BY SOURCE
5.1. Bacteria
5.1.1. Lactobacilli
5.1.1.1. Lactobacillus Acidophilus
5.1.1.2. Lactobacillus Rhamnosus
5.1.1.3. Lactobacillus Casei
5.1.1.4. Lactobacillus Reuteri
5.1.2. Bifidobacteria
5.3. Streptococcus
5.4. Bacillus
5.5. Yeast
CHAPTER 6 GLOBAL PROBIOTICS MARKET – BY FORM
6.1. Liquid
6.2. Dry
CHAPTER 7 GLOBAL PROBIOTICS MARKET – BY FUNCTION
7.1. Regular
7.2. Preventive Healthcare
7.3. Therapeutic
CHAPTER 8 GLOBAL PROBIOTICS MARKET – BY APPLICATION
8.1. Functional Food & Beverages
8.1.1. Dairy Products
8.1.2. Baked Goods
8.1.3. Non-Dairy Beverages
8.1.4. Fermented Meat
8.1.5. Cereals
8.2. Dietary Supplements
8.2.1. Food Supplements
8.2.2. Nutritional Supplements
8.2.3. Speciality Supplements
8.2.4. Infant Formula
8.3. Animal Feed
CHAPTER 9 GLOBAL PROBIOTICS MARKET – BY END USER
9.1. Human
9.2. Animal
CHAPTER 10 GLOBAL PROBIOTICS MARKET - BY GEOGRAPHY
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.2.3. Mexico
10.2.4. Costa Rica
10.3. South America
10.3.1. Brazil
10.3.2. Argentina
10.3.3. Chile
10.3.4. Columbia
10.3.5. Others
10.4. Europe
10.4.1. U.K.
10.4.2. Germany
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Russia
10.4.7. Netherlands
10.4.8. Switzerland
10.4.9. Poland
10.4.10. Others
10.5. APAC
10.5.1. China
10.5.2. Japan
10.5.3. India
10.5.4. South Korea
10.5.5. Australia & New Zealand
10.5.6. Malaysia
10.5.7. Singapore
10.5.8. Others
10.6. Middle East & Africa
10.6.1. UAE
10.6.2. Saudi Arabia
10.6.3. Iran
10.6.4. Iraq
10.6.5. Qatar
10.6.6. South Africa
10.6.7. Algeria
10.6.8. Morocco
10.6.9. Nigeria
10.6.10. Egypt
10.6.11. Others
CHAPTER 11 GLOBAL PROBIOTICS MARKET - COMPANY PROFILES
11.1. Nestle S.A.
11.2. Ganeden, Inc.
11.3. E.I. du Pont de Nemours and Company
11.4. Protexin
11.5. Lifeway Foods, Inc.
11.6. Probi AB
11.7. Yakult Honsha Co., Ltd
11.8. Chr. Hansen Holdings A/S
11.9. BioGaia AB
11.10. Danone
11.11. Pfizer, Inc.
11.12. Lallemand, Inc.
11.13. PharmaCare Laboratories
11.14. SymbioPharm GmbH
11.15. DowDuPont Inc.
CHAPTER 12 GLOBAL PROBIOTICS MARKET - COMPETITIVE LANDSCAPE
12.1. Market Share Analysis
12.2. Strategies adopted by top companies
12.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 13 MARKET INSIGHTS
13.1. Industry Experts Insights
13.2. Analysts Opinions
13.3. Investment Opportunities
CHAPTER 14 APPENDIX
14.1. List of Tables
14.2. List of Figures
